Weld Capital Management’s Insmed INSM Stock Holding History

Weld Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,124	Closed	-$486K	–	570
2020 Q3	$486K	Sell	15,124 -23,715	-61%	-$682K	0.19%	190
2020 Q2	$1.07M	Buy	+38,839	New	+$921K	0.42%	62
2019 Q1	–	Sell	-20,438	Closed	-$268K	–	761
2018 Q4	$268K	Buy	+20,438	New	+$326K	0.06%	522

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Weld Capital Management's INSM Position: Q4 2020 in Review

Weld Capital Management sold out of Insmed (INSM) in Q4 2020, closing a stake of 15,124 shares — an estimated $486K sold.

Weld Capital Management first reported a position in INSM in Q4 2018 and held it in 3 quarters. The position peaked at $1.07M in Q2 2020. 206 funds tracked by Wall St. Rank hold INSM as of Q4 2020.

Weld Capital Management reported no remaining Insmed position as of Q4 2020 after selling out during the quarter.
Weld Capital Management sold 15,124 Insmed shares in Q4 2020, an estimated $486K.
Weld Capital Management first reported a position in Insmed in Q4 2018 and held it in 3 quarters.
Weld Capital Management's Insmed position peaked at $1.07M in Q2 2020.
206 funds tracked by Wall St. Rank held Insmed as of Q4 2020.

Based on Weld Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.